Top Markets
Coin of the day
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Rang in aandelen #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Aandeelprijs
$0.00953895
Laatst gesynchroniseerd: 2024-05-22
Marktkapitalisatie
$1.28M
Verandering (1 dag)
0.06%
Verandering (1 jaar)
0.00%
Land
GB
Handel Evgen Pharma plc (EVG)

Categorie

Koersgeschiedenis voor Evgen Pharma plc (EVG)
Hoogste slotkoers: $0.01 op 2024-05-01

Laagste slotkoers: $0.49 op 2015-10-01
Koersgeschiedenis van Evgen Pharma plc van 2015 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 -54.58%
2023 -67.00%
2022 -8.24%
2021 -46.45%
2020 34.51%
2019 -54.10%
2018 2.85%
2017 -28.77%
2016 -24.59%
2015 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE